Ureteroscopy and tailored treatment of upper tract urothelial cancer: recent advances and unmet needs
BJU Int
.
2022 Jul;130(1):35-37.
doi: 10.1111/bju.15746.
Epub 2022 Apr 25.
Authors
Davide Loizzo
1
2
,
Savio D Pandolfo
1
3
,
Francesco Del Giudice
4
5
,
Clara Cerrato
6
,
Benjamin I Chung
5
,
Zhenjie Wu
7
,
Ciro Imbimbo
3
,
Pasquale Ditonno
2
,
Ithaar Derweesh
6
,
Riccardo Autorino
1
Affiliations
1
Division of Urology, Virginia Commonwealth University (VCU) Health, Richmond, VA, USA.
2
Urology, Andrology and Kidney Transplantation Unit, University of Bari, Bari, Italy.
3
Urology Unit, University 'Federico II', Naples, Italy.
4
Department of Maternal Infant and Urologic Sciences, 'Sapienza' University, Rome, Italy.
5
Department of Urology, Stanford Medical Center, Stanford, CA, USA.
6
Department of Urology, University of California San Diego, La Jolla, CA, USA.
7
Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
PMID:
35412680
DOI:
10.1111/bju.15746
No abstract available
Publication types
Letter
MeSH terms
Carcinoma, Transitional Cell* / therapy
Humans
Kidney Neoplasms* / surgery
Ureteral Neoplasms* / surgery
Ureteroscopy
Urinary Bladder Neoplasms*